Modeling Challenges of Ebola Virus–Host Dynamics during Infection and Treatment
Abstract
1. Introduction
2. Material and Methods
2.1. Patients
2.2. Mathematical Modeling
3. Results
4. Discussion
Supplementary Materials
Author Contributions
Funding
Conflicts of Interest
References
- Erb-Alvarez, J.; Wendelboe, A.M.; Chertow, D.S. Ebola Virus in the Democratic Republic of the Congo: Advances and Remaining Obstacles in Epidemic Control, Clinical Care, and Biomedical Research. Chest 2019. [Google Scholar] [CrossRef]
- Nguyen, V.K.; Hernandez-Vargas, E.A. Windows of opportunity for Ebola virus infection treatment and vaccination. Sci. Rep. 2017, 7, 8975. [Google Scholar] [CrossRef] [PubMed]
- Martyushev, A.; Nakaoka, S.; Sato, K.; Noda, T.; Iwami, S. Modelling Ebola virus dynamics: Implications for therapy. Antivir. Res. 2016, 135, 62–73. [Google Scholar] [CrossRef] [PubMed]
- Madelain, V.; Baize, S.; Jacquot, F.; Reynard, S.; Fizet, A.; Barron, S.; Solas, C.; Lacarelle, B.; Carbonnelle, C.; Mentre, F.; et al. Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies. Nat. Commun. 2018, 9, 4013. [Google Scholar] [CrossRef] [PubMed]
- Chertow, D.S.; Nath, A.; Suffredini, A.F.; Danner, R.L.; Reich, D.S.; Bishop, R.J.; Childs, R.W.; Arai, A.E.; Palmore, T.N.; Lane, H.C.; et al. Severe Meningoencephalitis in a Case of Ebola Virus Disease: A Case Report. Ann. Intern. Med. 2016, 165, 301–304. [Google Scholar] [CrossRef] [PubMed]
- Barnes, K.G.; Kindrachuk, J.; Lin, A.E.; Wohl, S.; Qu, J.; Tostenson, S.D.; Dorman, W.R.; Busby, M.; Siddle, K.J.; Luo, C.Y.; et al. Evidence of Ebola Virus Replication and High Concentration in Semen of a Patient During Recovery. Clin. Infect. Dis. 2017, 65, 1400–1403. [Google Scholar] [CrossRef] [PubMed]
- Kash, J.C.; Walters, K.A.; Kindrachuk, J.; Baxter, D.; Scherler, K.; Janosko, K.B.; Adams, R.D.; Herbert, A.S.; James, R.M.; Stonier, S.W.; et al. Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease. Sci. Transl. Med. 2017, 9. [Google Scholar] [CrossRef] [PubMed]
- Loomba, R.; Rivera, M.M.; McBurney, R.; Park, Y.; Haynes-Williams, V.; Rehermann, B.; Alter, H.J.; Herrine, S.K.; Liang, T.J.; Hoofnagle, J.H.; et al. The natural history of acute hepatitis C: Clinical presentation, laboratory findings and treatment outcomes. Aliment. Pharmacol. Ther. 2011, 33, 559–565. [Google Scholar] [CrossRef] [PubMed]
- Shteyer, E.; Shekhtman, L.; Zinger, T.; Harari, S.; Gafanovich, I.; Wolf, D.; Ivgi, H.; Barsuk, R.; Dery, I.; Armoni, D.; et al. Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography. PLoS ONE 2019, 14, e0210173. [Google Scholar] [CrossRef]
- Martines, R.B.; Ng, D.L.; Greer, P.W.; Rollin, P.E.; Zaki, S.R. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J. Pathol. 2015, 235, 153–174. [Google Scholar] [CrossRef] [PubMed]
- Baseler, L.; Chertow, D.S.; Johnson, K.M.; Feldmann, H.; Morens, D.M. The Pathogenesis of Ebola Virus Disease. Annu. Rev. Pathol. 2017, 12, 387–418. [Google Scholar] [CrossRef] [PubMed]
- Vetter, P.; Fischer, W.A.; Schibler, M.; Jacobs, M.; Bausch, D.G.; Kaiser, L. Ebola Virus Shedding and Transmission: Review of Current Evidence. J. Infect. Dis. 2016, 214, S177–S184. [Google Scholar] [CrossRef] [PubMed]
- Nathwani, R.A.; Pais, S.; Reynolds, T.B.; Kaplowitz, N. Serum alanine aminotransferase in skeletal muscle diseases. Hepatology 2005, 41, 380–382. [Google Scholar] [CrossRef] [PubMed]
- Hunt, L.; Gupta-Wright, A.; Simms, V.; Tamba, F.; Knott, V.; Tamba, K.; Heisenberg-Mansaray, S.; Tamba, E.; Sheriff, A.; Conteh, S.; et al. Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: An observational cohort study. Lancet Infect. Dis. 2015, 15, 1292–1299. [Google Scholar] [CrossRef]
- Warren, T.K.; Jordan, R.; Lo, M.K.; Ray, A.S.; Mackman, R.L.; Soloveva, V.; Siegel, D.; Perron, M.; Bannister, R.; Hui, H.C.; et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature 2016, 531, 381–385. [Google Scholar] [CrossRef] [PubMed]
- Cournac, J.M.; Karkowski, L.; Bordes, J.; Aletti, M.; Duron, S.; Janvier, F.; Foissaud, V.; Savini, H.; de Greslan, T.; Rousseau, C.; et al. Rhabdomyolysis in Ebola Virus Disease. Results of an Observational Study in a Treatment Center in Guinea. Clin. Infect. Dis. 2016, 62, 19–23. [Google Scholar] [CrossRef] [PubMed]
- Bennett, R.S.; Huzella, L.M.; Jahrling, P.B.; Bollinger, L.; Olinger, G.G., Jr.; Hensley, L.E. Nonhuman Primate Models of Ebola Virus Disease. Curr. Top. Microbiol. Immunol. 2017, 411, 171–193. [Google Scholar] [CrossRef]
- PREVAIL II Writing Group; Multi-National PREVAIL II Study Team; Davey, R.T., Jr.; Dodd, L.; Proschan, M.A.; Neaton, J.; Neuhaus Nordwall, J.; Koopmeiners, J.S.; Beigel, J.; Tierney, J.; et al. A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection. N. Engl. J. Med. 2016, 375, 1448–1456. [Google Scholar] [CrossRef]
- Mulangu, S.; Dodd, L.E.; Davey, R.T., Jr.; Tshiani Mbaya, O.; Proschan, M.; Mukadi, D.; Lusakibanza Manzo, M.; Nzolo, D.; Tshomba Oloma, A.; Ibanda, A.; et al. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics. N. Engl. J. Med. 2019. [Google Scholar] [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Chertow, D.S.; Shekhtman, L.; Lurie, Y.; Davey, R.T.; Heller, T.; Dahari, H. Modeling Challenges of Ebola Virus–Host Dynamics during Infection and Treatment. Viruses 2020, 12, 106. https://doi.org/10.3390/v12010106
Chertow DS, Shekhtman L, Lurie Y, Davey RT, Heller T, Dahari H. Modeling Challenges of Ebola Virus–Host Dynamics during Infection and Treatment. Viruses. 2020; 12(1):106. https://doi.org/10.3390/v12010106
Chicago/Turabian StyleChertow, Daniel S., Louis Shekhtman, Yoav Lurie, Richard T. Davey, Theo Heller, and Harel Dahari. 2020. "Modeling Challenges of Ebola Virus–Host Dynamics during Infection and Treatment" Viruses 12, no. 1: 106. https://doi.org/10.3390/v12010106
APA StyleChertow, D. S., Shekhtman, L., Lurie, Y., Davey, R. T., Heller, T., & Dahari, H. (2020). Modeling Challenges of Ebola Virus–Host Dynamics during Infection and Treatment. Viruses, 12(1), 106. https://doi.org/10.3390/v12010106